Old Web
English
Sign In
Acemap
>
authorDetail
>
Stefanie Rassnick
Stefanie Rassnick
Johnson & Johnson
Chemistry
Biochemistry
Parkinson's disease
Adenosine
Adenosine A1 receptor
6
Papers
165
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's Disease
2014
ACS Chemical Neuroscience
John R. Atack
Brian C. Shook
Stefanie Rassnick
Paul F. Jackson
Kenneth J. Rhodes
Wilhelmus Drinkenburg
Abdallah Ahnaou
Paula te Riele
Xavier Langlois
Brian Hrupka
Patrick De Haes
Herman M. R. Hendrickx
Nancy Aerts
Koen A. Hens
Annemie Wellens
Jef Vermeire
Anton Megens
Show All
Source
Cite
Save
Citations (30)
Overcoming the Genotoxicity of a Pyrrolidine Substituted Arylindenopyrimidine As a Potent Dual Adenosine A2A/A1 Antagonist by Minimizing Bioactivation to an Iminium Ion Reactive Intermediate
2011
Chemical Research in Toxicology
Heng-Keang Lim
Jie Chen
Carlo Sensenhauser
Kevin Cook
Robert Preston
Tynisha Thomas
Brian C. Shook
Paul F. Jackson
Stefanie Rassnick
Kenneth J. Rhodes
Vedwatee Gopaul
Rhys Salter
José M. Silva
David C. Evans
Show All
Source
Cite
Save
Citations (29)
Aminomethyl substituted thieno[2,3- d ]pyrimidines as adenosine A2A receptor antagonists
2011
MedChemComm
Brian C. Shook
Devraj Charavarty
J. Kent Barbay
Aihua Wang
Kristi Leonard
Vernon Alford
Mark P. Powell
Derek A. Beauchamp
Stefanie Rassnick
Robert H. Scannevin
Karen I. Carroll
Nathaniel H. Wallace
Jeffrey Crooke
Mark Ault
Lisa Lampron
Lori Westover
Kenneth J. Rhodes
Paul F. Jackson
Show All
Source
Cite
Save
Citations (10)
Relation of Misperception of Healthy Weight to Obesity in Urban Black Men
2010
Obesity
Job G. Godino
Stephen J. Lepore
Stefanie Rassnick
Show All
Source
Cite
Save
Citations (10)
1